Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00055055 · ClinicalTrials.gov registry record

Study of Families With Twins or Siblings Discordant for Rheumatic Disorders

A clinical trial of Rheumatoid Arthritis and Systemic Lupus Erythematosus, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Completed
Registry status
1,056
Enrollment target
3
Study locations

NCT00055055 is a study of Rheumatoid Arthritis and Systemic Lupus Erythematosus that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 1,056 participants, below the 4,685-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00055055, a study of Rheumatoid Arthritis and Systemic Lupus Erythematosus, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).

COMPLETED
Registry status
1,056 participants
Enrollment target
3
Study locations

Study Summary

This study will examine families in which one sibling of a sibling pair, or twin pair, has developed a systemic rheumatic disease and one has not, to see if and how the two differ in the following: * Blood cell metabolism; * Types of cells in the blood; * Environmental exposures or genetic factors that might explain why one developed disease and the other did not. Families in which one sibling has developed a systemic rheumatic disease, rheumatoid arthritis, systemic lupus erythematosus, scleroderma, dermatomyositis, or myositis, and the other has not, are eligible for this study. The siblings may or may not be twins, but must be of the same gender and be within a 5-year age difference. Biological parents, or, in some cases, children, will also be included in the study. Normal, healthy volunteers will serve as control subjects. Participants will undergo some or all of the following tests and procedures: * Medical history and physical examination. Participants will also be asked permission to obtain medical records for review. * Questionnaires about environmental exposures at work, at home, and elsewhere. Probands (participants with rheumatic disease) and their healthy siblings will also answer questions about infections, vaccinations, medications or dietary supplements, sun exposure, and stressful events during the year before disease diagnosis in the affected sibling. * Blood and urine collection for the following tests: * Routine blood chemistries and other studies to rule out certain diseases or medical problems; * Evidence of past toxic exposures and certain infections; * Presence of cells from the mother in the child s blood and vice versa. (Recent studies suggest that during pregnancy or delivery, cells from the mother and baby may be exchanged and circulate in the body for many years, possibly causing problems); * In twin or sibling pairs, presence of certain genes that may be more common in patients with systematic rheumatic diseases as compared with the

Study Locations (3)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

North Carolina

  • NIEHS Clinical Research Unit (CRU) - Research Triangle Park

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 1,056 participants
Start Date 2003-04-21

What the Registry Record Tells You About NCT00055055

The ClinicalTrials.gov registry entry for NCT00055055 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,056 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,685-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (77% lower). The listed sponsor is National Institute of Environmental Health Sciences (NIEHS), which has 145 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.

NCT00055055 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Maryland, North Carolina, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00055055 about?

NCT00055055 is a clinical study titled "Study of Families With Twins or Siblings Discordant for Rheumatic Disorders". This study will examine families in which one sibling of a sibling pair, or twin pair, has developed a systemic rheumatic disease and one has not, to see if and how the two differ in the following: * Blood cell metabolism; * Types of cells in the blood; * Environmental exposures or genetic factors ...

What is the current status of trial NCT00055055?

This trial is currently completed. The enrollment target is 1,056 participants. The study started on 2003-04-21.

What conditions does trial NCT00055055 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies.

Who is sponsoring clinical trial NCT00055055?

This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00055055 being conducted?

This trial has 3 study locations across Maryland, North Carolina, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.